Comparative Effects of Combination Therapies; Methotrexate with Leflunomide & Sulfasalazine in the Treatment of Rheumatoid Arthritis
Keywords:
Rheumatoid Arthritis, Methotrexate, Leflunomide, Sulfasalazine, Disease Modifying Anti-rheumatic DrugsAbstract
Objective: To study the role of combination therapies in the treatment of rheumatoid arthritis.
Methodology: This open-label, randomized 180-day clinical trial was conducted in the Department of Pharmacology and
Therapeutics, BMSI and Medical unit ward 6, after approval of JPMC ethical committee, in which enrolled patients were 89.
Patients were divided into two groups, A and B. 44 patients of group A received methotrexate (MTX) 7.5-20 mg/ week orally
and Leflunomide (LEF) 10-20 mg/ day orally as maximally tolerated. 45 patients of group B were given MTX 7.5-20 mg/ week
orally and Sulfasalazine (SSZ) 500 mg to 1 gm daily orally as maximally tolerated.
Result: Comparing the combination of group A with group B, group B showed highly significant improvement in mean swollen
joint count (1.9±0.9) and morning stiffness (46.0=19.06) as compared to group A (2.9=1.71, 54.4=10.14). The drugs of group
A showed significant improvement in mean pain (2.9= 1.71), physician’s global assessment (2.80±0.97) and patient’s global
assessment (1.4=0.66) as compared to group B (1.9= 1.45, 3.8±1.22, 2.0=0.99). Therefore, our study revealed that patients
receiving combination of MTX and LEF responded slightly better than MTX and SSZ. Both the combination treatments were
well tolerated.
Conclusion: Both combinations of MTX & SSZ and MTX & LEF were well tolerated but the efficacy of MTX and LEF was
marginally superior to combination of MTX and SSZ.
References
Majithia V, Geraci SA. Rheumatoid arthritis: diagnosis and management. Am J Med. 2007; 120: 936-39
Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41: 778-99
Farooqi A, Gibson T. Prevalence of the major rheumatic disorders in the adult population of North Pakistan. Br J Rheumatol. 1998; 37: 491-95
Alvarez-Lafuente R, Fernández Gutiérrez B, de Miguel S. Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction Ann Rheum Dis. 2005; 64:1 357-9
Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 Recommendations for the Use of Nonbiologic and Biologic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. Arthritis and Rheum. 2008; 59:7 62–84.
Fries JF, Williams CA, Morfeld D, Singh G, Sibley J. Reduction in long-term disability in patients with rheum- atoid arthritis by disease-modifying antirheumatic drug- based treatment strategies Arthritis Rheum. 1996; 39:61 6-22
Tugwell P, Pincus T, Yocum D, Stein M, Gluck O, Kraag G, et al. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med. 1995; 333:137-41
WHO Model List of Essential Medicines.World Health Organization, 2013. Retrieved 2014
Dougados M, Emery P, Lemmel EM, Zerbini CA, Brin S, van Riel P. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide? Ann Rheum Dis. 2005; 64:44–51
Pinto P, Dougados M. Leflunomide in clinical practice. Acta Reumatológica Portuguesa, 2006; 31:215–224
Gramling A, O’Dell JR. Initial management of rheum- atoid arthritis. Rheum Dis Clin North Am 2012; 38:311-25.
Oakley F, Meso M, Iredale JP, Green K, Marek CJ, Zhou X, et al. Inhibition of inhibitor of B kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterol. 2005;128: 108–20
Mc Girt LY, Vasagar K, Gober LM, Saini SS, Beck LA. Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Arch Dermatol. 2006; 142: 1337–42
James RO, Leff R, Paulsen G, Haire C, Mallek J, Eckhoff PJ, et al. Treatment of rheumatoid arthritis with methot- rexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: Results of a two-year, randomized, double-blind, placebo- controlled trial. Arthrits and Rheum. 2002; 46: 1164-70
Funke F, Reips UD. (PDF). Field Methods, 2012; 24:3 10–27
Reips U, Funke F. Interval-level measurement with visual analogue scales in Internet-based research: VAS Generator by University of Zürich, Zürich, Switzerland and University of Tübingen, Tübingen, Germany. Behavior Res Methods 2008; 40:699-704
Yazici Y, Pincus T, Kautiainen H, Sokka T. Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate. J Rheumatol. 2004; 31:1723–26
Pincus T, Sokka T. Quantitative measures for assessing rheumatoid arthritis in clinical trials and clinical care. Rheum Dis Clin North Am. 2004; 30:51-725
Adopted from National Institutes of Health Warren Grant Magnuson Clinical Center Pain Intensity Instruments 2003
Jobanputra W, Douglas K, Burls A. A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis. Rheum. 2004; 43:206-10
Calguneri M, Pay S, Caliskaner Z, Apras S, Kiraz S, Ertenli I, et al. Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis. Clin Exp Rheumatol. 1999; 17:699–704
Rantalaiho V, Korpela M, Hannonen P, Kautiainen H, Jarvenpaa S, Leirisalo-Repo M, et al, Fin-RACo Trial Group. The good initial response to therapy with a comb- ination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial. Arthritis Rheum. 2009; 60:1222-31
Haagsma CJ, van Riel PL, de Jong AJ, van de Putte LB. Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial. Br J Rheumatol 1997; 36(10):1082-8
Kremer JM, Genovese MC, Cannon GW, Caldwell JR Cush JJ, Furst DE, et al. Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2002; 137:726-33
Harris ED. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277–89
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Qurrat-ul-Ain Bukhari, Moosa Khan, Kausar Moin Mirza, Muzna Hameed Dar
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
